NEW YORK (GenomeWeb) – Investment bank Jefferies has lowered its rating on Sequenom to Hold from Buy following Sequenom's analyst day event this week that left the bank with "more questions than answers," Brandon Couillard, an equity analyst with Jefferies, wrote in a note.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.